Cote d'Ivoire vs North Macedonia: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Cote d'Ivoire
59.0%
in 2025
North Macedonia
60.0%
in 2025
Cote d'Ivoire rank
148th
North Macedonia rank
147th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Cote d'Ivoire
- North Macedonia
How they compare
North Macedonia currently reports 60.0% against 59.0% in Cote d'Ivoire, a difference of 1.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was North Macedonia ahead.
Cote d'Ivoire ranks 148th and North Macedonia ranks 147th of 194 countries.
Cote d'Ivoire has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cote d'Ivoire | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 39.1% | 0.0% | 39.1% | Cote d'Ivoire |
| 2020s | 60.5% | 54.5% | 6.0% | Cote d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Cote d'Ivoire or North Macedonia?
- North Macedonia, at 60.0% against 59.0% in Cote d'Ivoire as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Cote d'Ivoire and North Macedonia?
- 1.0%, with North Macedonia ahead.
- How many years of comparable data are there for Cote d'Ivoire and North Macedonia?
- 18 years are reported by both, from 2008 to 2025.
- How do Cote d'Ivoire and North Macedonia rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Cote d'Ivoire ranks 148th and North Macedonia ranks 147th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.